Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

KERNX Health vs MyFastRx

KERNX Health
Graded #276

Lower grade

vs+5.3999999999999915
MyFastRx
Graded #161

Higher grade

The verdict

MyFastRx takes it — 67.6/100 to 62.2/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +14
62
76
Dose & formulationMyFastRx +8
64
72
Clinical oversightKERNX Health +5
71
66
Labs & monitoringEven
52
52
FulfillmentMyFastRx +14
69
83
Contract termsKERNX Health +4
45
41
KERNX Health · left barMyFastRx · right bar

The numbers

MetricKERNX HealthMyFastRx
WeighScore62.2/10067.6/100
GradeCC
Scorecard rank#276#161
Semaglutide$129/mo (promotional rate, plus a separate fee, compounded)$169/mo
Tirzepatide$199/mo (promotional rate, plus a separate fee, compounded)$249/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
KERNX Health

Graded #276 · C

Strengths

  • Publishes plan pricing openly, before any intake or account creation
  • Month-to-month with no long-term contract and no multi-month prepayment
  • Billing starts only after a licensed provider approves treatment
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
  • The consultation fee is charged whether or not a prescription is issued
  • Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
  • No compounding pharmacy is named anywhere on the site
  • Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ
MyFastRx

Graded #161 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard